Literature DB >> 25816723

Forward-viewing versus oblique-viewing echoendoscopes in the diagnosis of upper GI subepithelial lesions with EUS-guided FNA: a prospective, randomized, crossover study.

Ippei Matsuzaki1, Ryoji Miyahara1, Yoshiki Hirooka2, Kohei Funasaka2, Eizaburo Ohno1, Masanao Nakamura1, Hiroki Kawashima1, Akiko Nukaga3, Yoshie Shimoyama3, Hidemi Goto4.   

Abstract

BACKGROUND: The role of the forward-viewing echoendoscope compared with the oblique-viewing echoendoscope for EUS-guided FNA (EUS-FNA) of upper GI subepithelial lesions has not been defined.
OBJECTIVE: To compare the diagnostic yield and clinical efficacy of EUS-FNA by using the 2 echoendoscopes in the same upper GI subepithelial lesion.
DESIGN: Prospective, randomized, crossover study.
SETTING: Tertiary-care medical center. PATIENTS: Forty-one patients with an upper GI subepithelial lesion.
INTERVENTIONS: All patients first underwent EUS-FNA with a 19-gauge needle by using both echoendoscopes, based on random selection. When required, 22-gauge or 25-gauge needles were used additionally. MAIN OUTCOME MEASUREMENTS: Comparison of diagnostic yield, tissue sample area, puncture success rates, procedure time, and adverse events.
RESULTS: Forty-one patients (median lesion size 22 mm, range 15-63 mm) were enrolled. Rates of histologic diagnosis were 80.5% (33/41) and 73.2% (30/41) (P=.453) by using forward-viewing and oblique-viewing echoendoscopes, respectively. Median tissue sample area in GI stromal tumors (n=22) obtained with the forward-viewing echoendoscope was larger than with the oblique-viewing echoendoscope (2.46 mm2 vs 1.00 mm2; P=.046). Puncture success rates were 39 of 41 (95.1%) and 35 of 41 (85.4%; P=.289) with forward-viewing and oblique-viewing echoendoscopes, respectively. Median procedure time was 21 minutes with the forward-viewing echoendoscope and 27 minutes with the oblique-viewing echoendoscope (P=.009). An infectious adverse event occurred in a patient and was treated with antibiotics. LIMITATIONS: Small sample size.
CONCLUSION: Diagnostic yield did not differ between the 2 echoendoscopes. However, tissue sample area and procedure time were superior with the forward-viewing echoendoscope.
Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25816723     DOI: 10.1016/j.gie.2014.12.051

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  13 in total

1.  Mucosal incision-assisted biopsy versus endoscopic ultrasound-assisted tissue acquisition for subepithelial lesions: a systematic review and meta-analysis.

Authors:  Suprabhat Giri; Shivaraj Afzalpurkar; Sumaswi Angadi; Sridhar Sundaram
Journal:  Clin Endosc       Date:  2022-08-04

Review 2.  Advancements in the Diagnosis of Gastric Subepithelial Tumors.

Authors:  Osamu Goto; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

3.  Endoscopic ultrasound-guided forceps biopsy from upper gastrointestinal subepithelial lesions using a forward-viewing echoendoscope.

Authors:  Ippei Matsuzaki; Ryoji Miyahara; Yoshiki Hirooka; Kohei Funasaka; Takeshi Yamamura; Eizaburo Ohno; Masanao Nakamura; Hiroki Kawashima; Osamu Watanabe; Makoto Kobayashi; Yoshie Shimoyama; Shigeo Nakamura; Hidemi Goto
Journal:  Endosc Int Open       Date:  2016-06

Review 4.  Endoscopic ultrasound: Current roles and future directions.

Authors:  Scott R Friedberg; Jesse Lachter
Journal:  World J Gastrointest Endosc       Date:  2017-10-16

5.  Comparison of submucosal tunneling biopsy versus EUS-guided FNA for gastric subepithelial lesions: a prospective study with crossover design.

Authors:  Hideki Kobara; Hirohito Mori; Naoki Nishimoto; Shintaro Fujihara; Noriko Nishiyama; Maki Ayaki; Tatsuo Yachida; Tae Matsunaga; Taiga Chiyo; Nobuya Kobayashi; Koji Fujita; Kiyohito Kato; Hideki Kamada; Makoto Oryu; Kunihiko Tsutsui; Hisakazu Iwama; Reiji Haba; Tsutomu Masaki
Journal:  Endosc Int Open       Date:  2017-08-03

6.  All-optical forward-viewing photoacoustic probe for high-resolution 3D endoscopy.

Authors:  Rehman Ansari; Edward Z Zhang; Adrien E Desjardins; Paul C Beard
Journal:  Light Sci Appl       Date:  2018-10-10       Impact factor: 17.782

7.  Clinical Impact of EUS-Guided Fine Needle Biopsy Using a Novel Franseen Needle for Histological Assessment of Pancreatic Diseases.

Authors:  Takuya Ishikawa; Hiroki Kawashima; Eizaburo Ohno; Hiroyuki Tanaka; Daisuke Sakai; Tadashi Iida; Ryo Nishio; Takeshi Yamamura; Kazuhiro Furukawa; Masanao Nakamura; Ryoji Miyahara; Senju Hashimoto; Masatoshi Ishigami; Yoshiki Hirooka
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-03

8.  Usefulness of Macroscopic On-Site Evaluation Using a Stereomicroscope during EUS-FNB for Diagnosing Solid Pancreatic Lesions.

Authors:  Takuya Ishikawa; Eizaburo Ohno; Yasuyuki Mizutani; Tadashi Iida; Kota Uetsuki; Jun Yashika; Kenta Yamada; Noriaki Gibo; Toshinori Aoki; Kunio Kataoka; Hiroshi Mori; Yoshihisa Takada; Hidekazu Takahashi; Hironori Aoi; Katsuyuki Kato; Takeshi Yamamura; Naomi Kakushima; Kazuhiro Furukawa; Masanao Nakamura; Yoshiki Hirooka; Hiroki Kawashima
Journal:  Can J Gastroenterol Hepatol       Date:  2022-01-18

9.  Performance of the forward-view echoendoscope for pancreaticobiliary examination in patients with status post-upper gastrointestinal surgery.

Authors:  Pietro Fusaroli; Marta Serrani; Andrea Lisotti; Maria Cristina D'Ercole; Liza Ceroni; Giancarlo Caletti
Journal:  Endosc Ultrasound       Date:  2015 Oct-Dec       Impact factor: 5.628

Review 10.  A comparison of the efficiency of 22G versus 25G needles in EUS-FNA for solid pancreatic mass assessment: A systematic review and meta-analysis.

Authors:  Hugo Gonçalo Guedes; Diogo Turiani Hourneaux de Moura; Ralph Braga Duarte; Martin Andres Coronel Cordero; Marcos Eduardo Lera Dos Santos; Spencer Cheng; Sergio Eiji Matuguma; Dalton Marques Chaves; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  Clinics (Sao Paulo)       Date:  2018-02-15       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.